Schueler Stephan

GMC: 6032444


Special Interests: Thoracic Surgery

I am a nationally and internationationally well established cardiac surgeon with expertise in all areas of adult cardiac surgery. My particular expertise is in heart failure surgery, especially mechanical assist devices. I have contributed over 2 decades to developements of heart and lung transplantation. I am leaading the largest program in the UK, and our team has pioneered a number of new developments in this field.
I have been an advocate for patients with advanced heart failure for more than a decade in the UK, and I have been an advisor for NICE most recently on destination therapy.
I am established in numerous international scientific societies, have been president, program chair, council chair in various sicieties. I am involved in international working groups on guidelines, etc.
I am involved in several scientific journals as asociate editor, and editorial board member, adn reviewer respectively.
I am an established researcher in several areas of LVAD therapy , heart and lung transplantation. In addition, I have pioneered several areas of minimally invasive and robotic surgery in the past
My surgical practice comprises most areas of adult cardiac surgery, mainly high risk pathologies, endstage heart disease, with previous surgical interventions.

Training Attended
No further information available
Qualifications & Accreditations

Medical School University Bonn/ Germnay

Training in Genberal surgery at Hannover Medical School

Training in Thoracic and Vasscular surgery at Hannover Medical School

Training in Cardiac surgery at Hannover MEdical School/ Germany

PhD Free University of Berlin / Germany 1992

Consultant Cardiothoracic and Vascular surgeon German Heart Centre Berlin

Professor for Cardiac Surgery University Dresden

Consultant Cardiac Surgeon Freeman Hospital Newcastle/ UK.


Additional Information
No further information available

Risk-adjusted in-hospital survival rate

This graph shows the “in hospital” survival rate of patients who are operated on by the individual surgeon/unit you have selected. “In hospital” means time the patient is in the hospital where they have had their operation. It does not include any time that patients may have spent in other hospitals, either before or after their heart operation.

The data has been through a complex methodology, including the variations in patient risk factors in order to give you a comparative base from which to work from. This means that the survival rates take into account the type and risk of patients being operated on for each surgeon/unit. This is known as risk adjusted survival.

The vertical axis shows the GMC number of the surgeon or the Hospital identifier. In brackets is the total number of patients operated on by the surgeon/unit and the percentage of patients for whom the survival is known. The horizontal axis is the percentage survival. The dashed vertical line shows the risk adjusted survival rate for the UK as a whole. The solid black horizontal line represents the surgeon/unit. What is important here is that the horizontal line crosses the vertical dashed line. If this occurs, it means that the surgeon/unit are within the expected outcomes given the case-mix and risk factors of the patients they operate on.

The icons that sit on the horizontal line should give you more information about your surgeon/team.

For example

The open square is the survival rate with no risk adjustments:
The X is the predicted survival with adjustments
The solid dot is the survival probability after the methodology has been applied.

  • If the solid dot is red it means survival is worse than expected
  • If the solid dot is black it means that it is within limits
  • If the solid dot is green it means that there is significantly higher survival than expected

There is a lot of information on these plots, but the takeaway message is that if the solid black line crosses the dashed vertical line then the survival rate for the surgeon/unit is within expectations and that there is no reason for any concern.

A more detailed explanation about these graphs and methodology can be found here: Graph Explanations

Data for period April 2016 – March 2019.
Risk Adjusted In-Hospital Survival Rate